16-8801910-G-T

Variant summary

Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PS3PM1PP2PP3_StrongPP5_Very_Strong

The NM_000303.3(PMM2):​c.178G>T​(p.Val60Leu) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000702 in 1,566,540 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV003841277: Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID:34277356)." and additional evidence is available in ClinVar.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000064 ( 0 hom. )

Consequence

PMM2
NM_000303.3 missense, splice_region

Scores

2
3
3
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8U:1

Conservation

PhyloP100: 9.34

Publications

2 publications found
Variant links:
Genes affected
PMM2 (HGNC:9115): (phosphomannomutase 2) The protein encoded by this gene catalyzes the isomerization of mannose 6-phosphate to mannose 1-phosphate, which is a precursor to GDP-mannose necessary for the synthesis of dolichol-P-oligosaccharides. Mutations in this gene have been shown to cause defects in glycoprotein biosynthesis, which manifests as carbohydrate-deficient glycoprotein syndrome type I. [provided by RefSeq, Jul 2008]
PMM2 Gene-Disease associations (from GenCC):
  • congenital disorder of glycosylation type I
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • PMM2-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • hyperinsulinemic hypoglycemia with polycystic kidney disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 19 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV003841277: Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 34277356).; SCV003922622: At least one publication reports experimental evidence that this variant affects mRNA splicing (example:Gonzalez-Dominguez_2021).; SCV005901582: "This variant has been subjected to functional analysis of this variant in an RNAm experiment (PMID: 34277356) has identified a Loss of function mechanism (PVS1)." Functional analysis of this variant in an RNAm experiment (PMID: 34277356) has identified a Loss of function mechanism (PVS1). However, since the provided text mentions the functional analysis in the context of PVS1 rather than PS3, and there's no explicit statement about PS3, the correct output should adhere strictly to the instructions: *"If the comment clearly states that PS3 should be applied, or if it gives a reference (like publication) it probably contains an evidence for PS3, so behave eagerly."* Given the instruction and the content, the closest match to the requirement would be: "functional analysis of this variant in an RNAm experiment (PMID: 34277356)" But strictly adhering to the requirement for PS3 evidence: `no`; SCV001831995: Studies in patient cells support this variant results in abnormal splicing (Gonzlez-Domnguez CA et al., 2021); This variant is associated with the following publications: (PMID: 26633542, 34277356); SCV005360846: RNA sequencing analysis performed using cultured patient fibroblasts confirmed that the c.178G>T variant disrupted splicing at the adjacent canonical splice donor site, leading to the activation of two intronic cryptic donor sites (González-Domínguez et al. 2021. PubMed ID: 34277356).
PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 6 uncertain in NM_000303.3
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 89 curated pathogenic missense variants (we use a threshold of 10). The gene has 24 curated benign missense variants. Gene score misZ: -1.3872 (below the threshold of 3.09). Trascript score misZ: -1.8083 (below the threshold of 3.09). GenCC associations: The gene is linked to PMM2-congenital disorder of glycosylation, congenital disorder of glycosylation type I, hyperinsulinemic hypoglycemia with polycystic kidney disease.
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 16-8801910-G-T is Pathogenic according to our data. Variant chr16-8801910-G-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 530390.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000303.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PMM2
NM_000303.3
MANE Select
c.178G>Tp.Val60Leu
missense splice_region
Exon 2 of 8NP_000294.1A0A0S2Z4J6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PMM2
ENST00000268261.9
TSL:1 MANE Select
c.178G>Tp.Val60Leu
missense splice_region
Exon 2 of 8ENSP00000268261.4O15305-1
PMM2
ENST00000565221.5
TSL:1
n.178G>T
splice_region non_coding_transcript_exon
Exon 2 of 6ENSP00000457932.1H3BV34
PMM2
ENST00000566540.5
TSL:1
n.178G>T
splice_region non_coding_transcript_exon
Exon 2 of 6ENSP00000454284.1H3BM92

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152160
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000245
AC:
6
AN:
245166
AF XY:
0.0000151
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000636
AC:
9
AN:
1414380
Hom.:
0
Cov.:
24
AF XY:
0.00000425
AC XY:
3
AN XY:
706232
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32412
American (AMR)
AF:
0.000202
AC:
9
AN:
44610
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25784
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39082
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84954
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53070
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5670
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1070106
Other (OTH)
AF:
0.00
AC:
0
AN:
58692
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152160
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74334
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
41430
American (AMR)
AF:
0.000131
AC:
2
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.00000000770867), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.400
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.0000330
AC:
4

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
6
1
-
PMM2-congenital disorder of glycosylation (7)
1
-
-
not provided (1)
1
-
-
PMM2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.50
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Pathogenic
0.31
CADD
Pathogenic
34
DANN
Uncertain
1.0
Eigen
Benign
-0.087
Eigen_PC
Benign
0.10
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Uncertain
0.20
D
PhyloP100
9.3
Vest4
0.85
ClinPred
0.27
T
GERP RS
5.7
RBP_binding_hub_radar
0.85
RBP_regulation_power_radar
2.6
Varity_R
0.54
Mutation Taster
=1/199
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
1.0
SpliceAI score (max)
0.51
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.51
Position offset: 28
DS_DL_spliceai
0.43
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759513930; hg19: chr16-8895767; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.